Loading...
Harvey Norman Holdings Limited
HNORY•PNK
Consumer Cyclical
Specialty Retail
$12.50
$0.00(0.00%)
Harvey Norman Holdings Limited (HNORY) Financial Performance & Income Statement Overview
Review Harvey Norman Holdings Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.55%
↓ 1.55%
Operating Income Growth
-53.55%
↓ 53.55%
Net Income Growth
-34.67%
↓ 34.67%
Operating Cash Flow Growth
0.92%
↑ 0.92%
Operating Margin
3.05%
↑ 3.05%
Gross Margin
40.54%
↑ 40.54%
Net Profit Margin
10.41%
↑ 10.41%
ROE
7.85%
↑ 7.85%
ROIC
1.45%
↑ 1.45%
Harvey Norman Holdings Limited (HNORY) Income Statement & Financial Overview
Review Harvey Norman Holdings Limited's (HNORY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $1.33B | $2.06B | $1.84B | $2.14B |
| Cost of Revenue | $914.01M | $1.10B | $957.65M | $1.09B |
| Gross Profit | $411.80M | $961.38M | $882.28M | $1.06B |
| Gross Profit Ratio | $0.31 | $0.47 | $0.48 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $660.72M | $609.06M | $575.27M | $585.74M |
| Operating Expenses | $660.72M | $609.06M | $575.27M | $585.74M |
| Total Costs & Expenses | $1.57B | $1.71B | $1.53B | $1.67B |
| Interest Income | $9.28M | $9.51M | $8.95M | $6.68M |
| Interest Expense | $56.61M | $54.37M | $51.95M | $39.70M |
| Depreciation & Amortization | $39.99M | $82.75M | $82.07M | $78.78M |
| EBITDA | $338.74M | $414.57M | $382.29M | $636.46M |
| EBITDA Ratio | $0.26 | $0.21 | $0.21 | $0.26 |
| Operating Income | -$248.93M | $352.32M | $307.01M | $470.70M |
| Operating Income Ratio | -$0.19 | $0.17 | $0.17 | $0.22 |
| Other Income/Expenses (Net) | $507.03M | -$74.87M | -$58.75M | $51.98M |
| Income Before Tax | $258.10M | $277.45M | $248.26M | $517.97M |
| Income Before Tax Ratio | $0.19 | $0.13 | $0.13 | $0.24 |
| Income Tax Expense | $103.26M | $80.80M | $76.32M | $152.92M |
| Net Income | $152.44M | $200.01M | $173.62M | $365.90M |
| Net Income Ratio | $0.11 | $0.10 | $0.09 | $0.17 |
| EPS | $0.12 | $0.16 | $0.14 | $0.29 |
| Diluted EPS | $0.12 | $0.16 | $0.14 | $0.29 |
| Weighted Avg Shares Outstanding | $1.25B | $1.25B | $1.25B | $1.25B |
| Weighted Avg Shares Outstanding (Diluted) | $1.25B | $1.25B | $1.25B | $1.25B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan